Nirman Agri Genetics Past Earnings Performance
Past criteria checks 1/6
Nirman Agri Genetics has been growing earnings at an average annual rate of 56.5%, while the Biotechs industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 112.1% per year. Nirman Agri Genetics's return on equity is 14.9%, and it has net margins of 14%.
Key information
56.5%
Earnings growth rate
-32.8%
EPS growth rate
| Biotechs Industry Growth | 5.1% |
| Revenue growth rate | 112.1% |
| Return on equity | 14.9% |
| Net Margin | 14.0% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Nirman Agri Genetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 286 | 40 | 10 | 0 |
| 31 Mar 22 | 135 | 26 | 5 | 0 |
| 31 Mar 21 | 66 | 1 | 3 | 0 |
Quality Earnings: NIRMAN has a high level of non-cash earnings.
Growing Profit Margin: NIRMAN's current net profit margins (14%) are lower than last year (19%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NIRMAN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare NIRMAN's past year earnings growth to its 5-year average.
Earnings vs Industry: NIRMAN earnings growth over the past year (56.5%) exceeded the Biotechs industry -2.9%.
Return on Equity
High ROE: NIRMAN's Return on Equity (14.9%) is considered low.